share_log

AbbVie | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Feb 21 18:02
Summary by Moomoo AI
AbbVie Inc. officer, Azita Saleki-Gerhardt, is set to sell 52,870 shares of the company's common stock on February 21, 2024, according to a recent filing. The shares, valued at approximately $9,184,486.84, were acquired on the same date through a stock option exercise as part of compensation from the issuer. This transaction follows a period where no significant sales activity was reported by Saleki-Gerhardt in the past three months.
AbbVie Inc. officer, Azita Saleki-Gerhardt, is set to sell 52,870 shares of the company's common stock on February 21, 2024, according to a recent filing. The shares, valued at approximately $9,184,486.84, were acquired on the same date through a stock option exercise as part of compensation from the issuer. This transaction follows a period where no significant sales activity was reported by Saleki-Gerhardt in the past three months.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more